相似文献
1
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.
Biol Blood Marrow Transplant. 2008 Oct;14(10):1172-1179. doi: 10.1016/j.bbmt.2008.08.003.
2
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells.
Int J Mol Sci. 2023 May 3;24(9):8204. doi: 10.3390/ijms24098204.
3
Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.
Osteoarthritis Cartilage. 2007 Apr;15(4):475-8. doi: 10.1016/j.joca.2006.11.007. Epub 2007 Jan 3.
4
Evidence for persistence of human parvovirus B19 DNA in bone marrow.
J Med Virol. 1997 Nov;53(3):229-32.
5
High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
Stem Cell Res Ther. 2018 Mar 27;9(1):80. doi: 10.1186/s13287-018-0811-7.
6
Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
Vox Sang. 2011 Apr;100(3):261-6. doi: 10.1111/j.1423-0410.2010.01423.x. Epub 2010 Oct 15.
7
Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Transpl Infect Dis. 2008 Jun;10(3):201-5. doi: 10.1111/j.1399-3062.2007.00266.x. Epub 2007 Jul 12.
8
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
J Med Virol. 2005 Jan;75(1):161-9. doi: 10.1002/jmv.20251.
9
Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
J Med Virol. 1998 Nov;56(3):199-204.
10
Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells.
Biochem Genet. 2020 Feb;58(1):63-73. doi: 10.1007/s10528-019-09928-y. Epub 2019 Jun 27.
引用本文的文献
1
Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.
Health Sci Rep. 2024 Apr 21;7(4):e2036. doi: 10.1002/hsr2.2036. eCollection 2024 Apr.
2
Stromal cell therapy in cats with feline chronic gingivostomatitis: current perspectives and future direction.
J Feline Med Surg. 2023 Aug;25(8):1098612X231185395. doi: 10.1177/1098612X231185395.
3
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells.
Int J Mol Sci. 2023 May 3;24(9):8204. doi: 10.3390/ijms24098204.
4
Liver Disease and Cell Therapy: Advances Made and Remaining Challenges.
Stem Cells. 2023 Aug 16;41(8):739-761. doi: 10.1093/stmcls/sxad029.
5
Adverse events, side effects and complications in mesenchymal stromal cell-based therapies.
Stem Cell Investig. 2022 Nov 8;9:7. doi: 10.21037/sci-2022-025. eCollection 2022.
6
Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy.
Front Med (Lausanne). 2021 Jul 21;8:708744. doi: 10.3389/fmed.2021.708744. eCollection 2021.
7
Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.
World J Stem Cells. 2021 Jun 26;13(6):568-593. doi: 10.4252/wjsc.v13.i6.568.
8
The Human Bone Marrow Is Host to the DNAs of Several Viruses.
Front Cell Infect Microbiol. 2021 Apr 22;11:657245. doi: 10.3389/fcimb.2021.657245. eCollection 2021.
9
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.
Viruses. 2020 Dec 18;12(12):1467. doi: 10.3390/v12121467.
10
Parvovirus B19 Infection in Human Bone Marrow Mesenchymal Stem Cells Affects Gene Expression of IL-6 and TNF-α and also Affects Hematopoietic Stem Cells Differentiation.
Indian J Hematol Blood Transfus. 2019 Oct;35(4):765-772. doi: 10.1007/s12288-019-01097-7. Epub 2019 Mar 2.
本文引用的文献
1
Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation.
Int J Mol Med. 2008 Mar;21(3):271-9.
2
Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
J Virol. 2008 Mar;82(5):2470-6. doi: 10.1128/JVI.02247-07. Epub 2007 Dec 26.
3
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Leukemia. 2007 Aug;21(8):1733-8. doi: 10.1038/sj.leu.2404777. Epub 2007 May 31.
4
Risk assessment in haematopoietic stem cell transplantation: viral status.
Best Pract Res Clin Haematol. 2007 Jun;20(2):209-17. doi: 10.1016/j.beha.2006.09.003.
5
Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.
Osteoarthritis Cartilage. 2007 Apr;15(4):475-8. doi: 10.1016/j.joca.2006.11.007. Epub 2007 Jan 3.
6
Clinical aspects of parvovirus B19 infection.
J Intern Med. 2006 Oct;260(4):285-304. doi: 10.1111/j.1365-2796.2006.01697.x.
7
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905.
8
9
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Transplantation. 2006 May 27;81(10):1390-7. doi: 10.1097/01.tp.0000214462.63943.14.
10
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
Bone Marrow Transplant. 2006 Jun;37(11):1051-9. doi: 10.1038/sj.bmt.1705368.
Zotero 插件